Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Werewolf Therapeutics (HOWL) Current Leases (2021 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Current Leases for 5 consecutive years, with $1.8 million as the latest value for Q4 2025.

  • Quarterly Current Leases rose 12.46% to $1.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Dec 2025, up 12.46% year-over-year, with the annual reading at $1.8 million for FY2025, 12.46% up from the prior year.
  • Current Leases for Q4 2025 was $1.8 million at Werewolf Therapeutics, up from $1.5 million in the prior quarter.
  • The five-year high for Current Leases was $2.1 million in Q1 2023, with the low at $699000.0 in Q1 2021.
  • Average Current Leases over 5 years is $1.5 million, with a median of $1.5 million recorded in 2022.
  • The sharpest move saw Current Leases soared 171.51% in 2022, then crashed 42.4% in 2024.
  • Over 5 years, Current Leases stood at $1.1 million in 2021, then skyrocketed by 94.4% to $2.1 million in 2022, then fell by 22.84% to $1.6 million in 2023, then dropped by 3.17% to $1.6 million in 2024, then rose by 12.46% to $1.8 million in 2025.
  • According to Business Quant data, Current Leases over the past three periods came in at $1.8 million, $1.5 million, and $1.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.